Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thomas Dirschka, Girish Gupta, Giuseppe Micali, Eggert Stockfleth, Nicole Basset-Séguin, Véronique Del Marmol, Reinhard Dummer, Gregor B. E. Jemec, Josep Malvehy, Ketty Peris, Susana Puig, Alexander J. Stratigos, Iris Zalaudek & Giovanni Pellacani. (2017) Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. Journal of Dermatological Treatment 28:5, pages 431-442.
Read now
Read now
Maria Goncalves-Maia & Thierry Magnaldo. (2017) Genetic therapy of Xeroderma Pigmentosum: analysis of strategies and translation. Expert Opinion on Orphan Drugs 5:1, pages 5-17.
Read now
Read now
Silvia Pandolfi & Barbara Stecca. (2015) Hedgehog-Gli signaling in basal cell carcinoma and other skin cancers: prospects for therapy. Research and Reports in Biology 6, pages 55-71.
Read now
Read now
Seval Doğruk Kaçar, Pınar Özuğuz, Faruk Erkan & Şemsettin Karaca. (2015) Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series. Journal of Dermatological Treatment 26:2, pages 165-167.
Read now
Read now
Giuseppe Micali, Francesco Lacarrubba, Karishma Bhatt & Maria Rita Nasca. (2013) Medical approaches to non-melanoma skin cancer. Expert Review of Anticancer Therapy 13:12, pages 1409-1421.
Read now
Read now
Articles from other publishers (13)
Mozammel Hossain, Ashraful Hasan, MohammadMahfuz Ali Khan Shawan, Subrata Banik & Iffat Jahan. (2021) Current Therapeutic Strategies of Xeroderma Pigmentosum. Indian Journal of Dermatology 66:6, pages 660.
Crossref
Crossref
Marina França Dias, Bruna Caroline Pinheiro de Figueiredo, Júlia Teixeira-Neto, Maria Carolina Andrade Guerra, Silvia Ligório Fialho & Armando Silva Cunha. (2018) In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles. Biomedicine & Pharmacotherapy 103, pages 1107-1114.
Crossref
Crossref
Holger Hackstein, Inna Tschipakow, Gregor Bein, Philipp Nold, Cornelia Brendel & Nelli Baal. (2016) Contact-dependent abrogation of bone marrow-derived plasmacytoid dendritic cell differentiation by murine mesenchymal stem cells. Biochemical and Biophysical Research Communications 476:1, pages 15-20.
Crossref
Crossref
Jian-Qiang Yang, Xian-Yu Chen, Michelle Yixiao Engle & Jian-You Wang. (2015) Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream. Dermatologic Therapy 28:4, pages 243-247.
Crossref
Crossref
Silvia Pandolfi & Barbara Stecca. (2015) Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy. Expert Reviews in Molecular Medicine 17.
Crossref
Crossref
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca & Robert A. Schwartz. (2014) Topical pharmacotherapy for skin cancer. Journal of the American Academy of Dermatology 70:6, pages 965.e1-965.e12.
Crossref
Crossref
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca, Salvatore Ferraro & Robert A. Schwartz. (2014) Topical pharmacotherapy for skin cancer. Journal of the American Academy of Dermatology 70:6, pages 979.e1-979.e12.
Crossref
Crossref
F Wolff, A Loipetzberger, W Gruber, H Esterbauer, F Aberger & A M Frischauf. (2013) Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation. Oncogene 32:50, pages 5574-5581.
Crossref
Crossref
Nassima Oumata, Phu hai Nguyen, Vincent Beringue, Flavie Soubigou, Yanhong Pang, Nathalie Desban, Catherine Massacrier, Yannis Morel, Carine Paturel, Marie-Astrid Contesse, Serge Bouaziz, Suparna Sanyal, Herv? Galons, Marc Blondel & C?cile Voisset. (2013) The Toll-Like Receptor Agonist Imiquimod Is Active against Prions. PLoS ONE 8:8, pages e72112.
Crossref
Crossref
Karen C. Galvin, Lydia Dyck, Neil A. Marshall, Anna M. Stefanska, Kevin P. Walsh, Barry Moran, Sarah C. Higgins, Lara S. Dungan & Kingston H. G. Mills. (2013) Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells. Cancer Immunology, Immunotherapy 62:7, pages 1273-1282.
Crossref
Crossref
Timothy J. Sullivan. (2012) Topical therapies for periorbital cutaneous malignancies. Current Opinion in Ophthalmology 23:5, pages 439-442.
Crossref
Crossref
Mohsen Daneshtalab & Zeinab Mahmoud. (2012) Imidazoquinolines as Diverse and Interesting Building Blocks: Review of Synthetic Methodologies. HETEROCYCLES 85:11, pages 2651.
Crossref
Crossref
Heleen D. de Koning, Anna Simon, Patrick L.J.M. Zeeuwen & Joost Schalkwijk. (2012) Pattern Recognition Receptors in Immune Disorders Affecting the Skin. Journal of Innate Immunity 4:3, pages 225-240.
Crossref
Crossref